AHEAD OF ACIP VOTE ON WHETHER TO WITHDRAW RECOMMENDATION FOR J&J VACCINE, ICAN AGAIN WRITES TO CDC AND FDA REGARDING CONCERN J&J VACCINE CHANGES DNA IN THE VACCINEE

ICAN, through its attorneys, has once again written to the CDC and FDA in advance of decisions to be made about the continued use of the J&J/Janssen vaccine to ask: “Can you still maintain that it is not possible for COVID-19 vaccines to change the DNA of the vaccinee?”

 ICAN previously wrote to the CDC regarding scientific support that the J&J/Janssen vaccine can change the DNA of the person receiving this product.  This is based on a study from the Department of Microbiology, Immunology & Molecular Genetics, UCLA School of Medicine and the Department of Genetics, Hyogo College of Medicine, Nishinomiya, Japan, which states: “studies have shown that replication-incompetent adenoviral vectors randomly integrate into host chromosomes at frequencies of 0.001-1% of infected cells.”

ICAN has now written to the FDA and CDC again to remind them of this issue as they consider whether to withdraw authorization of the J&J vaccine.

At the same time, ICAN also sent a letter to the FDA forwarding a comment submitted to the FDA on December 8, 2020 by Dr. Patrick Whelan at UCLA Pediatric Rheumatology.  Dr. Whelan raised concerns “about the possibility that the new vaccines aimed at creating immunity against the SARS-CoV-2 spike protein (including the mRNA vaccines of Moderna and Pfizer) have the potential to cause microvascular injury to the brain, heart, liver, and kidneys in a way that is not currently being assessed in safety trials of these potential drugs.”  ICAN believes it is crucial that if the FDA missed or dismissed this potential safety issue before it issued emergency use authorizations, it should certainly pay attention now in light of the serious and potentially fatal issues that are arising with the J&J vaccine.

ICAN will keep fighting to assure that our federal health agencies are held accountable for their actions as they engage in a religious drive to push vaccine products.